230 results on '"Tamtaji, Omid Reza"'
Search Results
2. Can infliximab serve as a new therapy for neuropsychiatric symptoms?
3. Non-Coding RNAs and Neurodegenerative Diseases: Information of their Roles in Apoptosis
4. Potential of Edaravone Dexborneol in the treatment of cerebral ischemia: focus on cell death-related signaling pathways
5. Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders
6. The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer’s and Parkinson’s Diseases
7. Non-coding RNAs and Aquaporin 4: Their Role in the Pathogenesis of Neurological Disorders
8. Outsmarting trogocytosis to boost CAR NK/T cell therapy
9. The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy
10. Probiotics and the Treatment of Parkinson's Disease: An Update
11. Can Berberine Serve as a New Therapy for Parkinson’s Disease?
12. Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target
13. Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms
14. Effects of flaxseed oil supplementation on biomarkers of inflammation and oxidative stress in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials
15. A systematic review and meta-analysis: The effects of probiotic supplementation on metabolic profile in patients with neurological disorders
16. Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial
17. The correlation of helios and neuropilin-1 frequencies with parkinson disease severity
18. A Genetic Association Study of MTHFR C677T Polymorphism with Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis
19. The effects of vitamin D supplementation on expanded disability status scale in people with multiple sclerosis: A critical, systematic review and metaanalysis of randomized controlled trials
20. Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms
21. How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial
22. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial
23. Increased serum levels of TNF-α and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity
24. The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
25. Correlation of serum levels and gene expression of tumor necrosis factor-α-induced protein-8 like-2 with Parkinson disease severity
26. PIWI-interacting RNAs and PIWI proteins in glioma: molecular pathogenesis and role as biomarkers
27. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial
28. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
29. The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
30. The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial
31. The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome
32. Non-coding RNAs and glioma: Focus on cancer stem cells
33. Quercetin and Glioma: Which Signaling Pathways are Involved?
34. Non-Coding RNAs and Brain Tumors: Insights Into Their Roles in Apoptosis
35. An Update on the Effects of Probiotics on Gastrointestinal Cancers
36. Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights into its Regulatory Mechanisms
37. Probiotics and the Treatment of Parkinson's Disease: An Update
38. Aquaporin 4 and brain-related disorders: Insights into its apoptosis roles
39. The Wound Healing Effects of Herbal Cream Containing Oliveria Decumbens and Pelargonium Graveolens Essential Oils in Diabetic Foot Ulcer Model
40. Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis
41. Breast cancer risk factors in Iran: a systematic review & meta-analysis
42. Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study
43. Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms
44. The Therapeutic Potential of Quercetin in Parkinson’s Disease: Insights into its Molecular and Cellular Regulation
45. Breast Cancer Risk Factors in Iran: A Systematic Review and Meta-analysis
46. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial
47. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017
48. Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms
49. New trends in glioma cancer therapy: Targeting Na + /H + exchangers
50. A Genetic Association Study of MTHFR C677T Polymorphism with Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.